CareDx Showcases Precision Medicine at the 2026 American Transplant Congress
CareDx, Inc. announced its participation at the 2026 American Transplant Congress, featuring over 30 abstracts and 9 oral presentations highlighting advancements in precision medicine diagnostics, particularly involving AlloSure® Kidney for transplant patients.
BRISBANE, Calif.–(BUSINESS WIRE)–CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant patients and caregivers, today announced its participation at the American Transplant Congress (ATC) 2026, taking place June 20–24 in Boston, Massachusetts. Real-world clinical use and scientific advancements involving AlloSure® Kidne